CH649222A5 - Composizione farmaceutica per uso terapeutico, per uso diagnostico e quale integratore alimentare. - Google Patents

Composizione farmaceutica per uso terapeutico, per uso diagnostico e quale integratore alimentare. Download PDF

Info

Publication number
CH649222A5
CH649222A5 CH4268/81A CH426881A CH649222A5 CH 649222 A5 CH649222 A5 CH 649222A5 CH 4268/81 A CH4268/81 A CH 4268/81A CH 426881 A CH426881 A CH 426881A CH 649222 A5 CH649222 A5 CH 649222A5
Authority
CH
Switzerland
Prior art keywords
arginine
pharmaceutical composition
lysine
composition according
diagnostic
Prior art date
Application number
CH4268/81A
Other languages
English (en)
Italian (it)
Inventor
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Publication of CH649222A5 publication Critical patent/CH649222A5/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH4268/81A 1980-06-30 1981-06-29 Composizione farmaceutica per uso terapeutico, per uso diagnostico e quale integratore alimentare. CH649222A5 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23101/80A IT1131854B (it) 1980-06-30 1980-06-30 Composizione farmaceutica per uso terapeutico,per uso diagnostico e quale integratore alimentare

Publications (1)

Publication Number Publication Date
CH649222A5 true CH649222A5 (it) 1985-05-15

Family

ID=11203787

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4268/81A CH649222A5 (it) 1980-06-30 1981-06-29 Composizione farmaceutica per uso terapeutico, per uso diagnostico e quale integratore alimentare.

Country Status (9)

Country Link
JP (1) JPS5714530A (fr)
AU (1) AU560450B2 (fr)
CH (1) CH649222A5 (fr)
DE (1) DE3115322A1 (fr)
FR (1) FR2485371A1 (fr)
GB (1) GB2078516B (fr)
IT (1) IT1131854B (fr)
PT (1) PT73286B (fr)
ZA (1) ZA814430B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314079A1 (de) * 1982-04-19 1983-12-22 Papst Motoren Gmbh & Co Kg Mehrwellenlaufwerk fuer kassetierte signaltraeger
DE3242501C1 (de) * 1982-11-18 1984-03-29 Degussa Ag, 6000 Frankfurt Verwendung von waessrigen L-Lysin-Loesungen zur Supplementierung von Futtermitteln mit L-Lysin
FR2568124B1 (fr) * 1984-07-24 1988-12-09 Cortial Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
US5077313A (en) * 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
US6143786A (en) * 1999-02-02 2000-11-07 Novartis Nutrition Ag Oral arginine and insulin secretion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6588M (fr) * 1967-10-11 1968-12-30

Also Published As

Publication number Publication date
AU560450B2 (en) 1987-04-09
AU7233681A (en) 1982-01-14
PT73286B (en) 1982-07-22
IT1131854B (it) 1986-06-25
PT73286A (en) 1981-07-01
ZA814430B (en) 1982-09-29
DE3115322A1 (de) 1982-04-08
IT8023101A0 (it) 1980-06-30
JPS5714530A (en) 1982-01-25
FR2485371B1 (fr) 1985-04-12
GB2078516A (en) 1982-01-13
GB2078516B (en) 1985-02-27
FR2485371A1 (fr) 1981-12-31

Similar Documents

Publication Publication Date Title
EP0742714B1 (fr) Compositions pharmaceutiques liquides comprenant des hormones thyroidiennes
DEVLIN et al. Captopril in human blood and breast milk
US8722115B2 (en) Methods for improving health in animals
US9238024B2 (en) Methods for improving health in canines
US8734864B2 (en) Methods for increasing human growth hormone levels
Kauppila et al. Metoclopramide and breast feeding: efficacy and anterior pituitary responses of the mother and the child
US8808763B2 (en) Methods for improving sleep efficiency in healthy human beings
CH655009A5 (it) Composizioni utili per la profilassi dell'iperlattacidemia.
Needs et al. Antirheumatic medication during lactation
CH649222A5 (it) Composizione farmaceutica per uso terapeutico, per uso diagnostico e quale integratore alimentare.
JPH10287560A (ja) 医薬組成物
US20160000716A1 (en) Method of treating vitamin b12 deficiency
WO2020093014A1 (fr) Compositions de médicament
DE602004011275T2 (de) Zusammensetzungen und Verfahren zur Behandlung von Fettleibigkeit
CA2086754C (fr) Traitement de l'absence de montee laiteuse chez la femme
US20160008369A1 (en) Oral formulation and suspension of an oncology drug
Kurlan Dietary therapy for motor fluctuations in Parkinson's disease
JP3096052B2 (ja) 脂質代謝調節剤
JPH04342528A (ja) アルコール代謝およびアセトアルデヒド代謝促進剤
Reimold Chlorpropamide in the treatment of diabetes insipidus in children
EP3345592A1 (fr) Formulations de kétorolac à stabilité améliorée et procédés et dispositifs à utiliser avec celles-ci
KR20140145508A (ko) 암브록솔 및 레보드로프로피진을 포함하는 안정성이 개선된 경구용 액상 제제
Sakai et al. Effects of an anabolic steroid and vitamin B complex upon myophaty induced by corticosteroids
GB2199243A (en) Pharmaceutical compositions comprising ornithine and arginine
JPH01501708A (ja) アミノ酸の経鼻投与

Legal Events

Date Code Title Description
PL Patent ceased